These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34890802)

  • 41. Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies.
    Waissi W; Paix A; Nicol A; Noël G; Burckel H
    Crit Rev Oncol Hematol; 2020 Sep; 153():103060. PubMed ID: 32707435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts in radiotherapy and their impact on oncology.
    Fletcher GH
    Curr Probl Cancer; 1983 Oct; 8(4):1-36. PubMed ID: 6357638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential usefulness of radiosensitizers in glioblastoma.
    Harasaki Y; Waziri A
    Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines.
    Lautenschlaeger T; Perry J; Peereboom D; Li B; Ibrahim A; Huebner A; Meng W; White J; Chakravarti A
    Radiat Oncol; 2013 Oct; 8():246. PubMed ID: 24153102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.
    Tallet AV; Azria D; Le Rhun E; Barlesi F; Carpentier AF; Gonçalves A; Taillibert S; Dhermain F; Spano JP; Metellus P
    Int J Mol Sci; 2014 May; 15(5):8138-52. PubMed ID: 24815073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silica-coated iron oxide nanoparticles as a novel nano-radiosensitizer for electron therapy.
    Fathy MM; Fahmy HM; Saad OA; Elshemey WM
    Life Sci; 2019 Oct; 234():116756. PubMed ID: 31419444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.
    Harms W; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Krug D; Piroth MD; Sautter-Bihl ML; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2016 Apr; 192(4):199-208. PubMed ID: 26931319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts.
    Sambade MJ; Kimple RJ; Camp JT; Peters E; Livasy CA; Sartor CI; Shields JM
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):575-81. PubMed ID: 20457354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoparticles promise new methods to boost oncology outcomes in breast cancer.
    Islamian JP; Hatamian M; Rashidi MR
    Asian Pac J Cancer Prev; 2015; 16(5):1683-6. PubMed ID: 25773810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update.
    Malik A; Sultana M; Qazi A; Qazi MH; Parveen G; Waquar S; Ashraf AB; Rasool M
    Anal Cell Pathol (Amst); 2016; 2016():6146595. PubMed ID: 26998418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
    Yong Y; Zhang C; Gu Z; Du J; Guo Z; Dong X; Xie J; Zhang G; Liu X; Zhao Y
    ACS Nano; 2017 Jul; 11(7):7164-7176. PubMed ID: 28640996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization.
    Gee JM; Nicholson RI
    Breast Cancer Res; 2003; 5(3):126-9. PubMed ID: 12793892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.
    Ogawa Y; Ue H; Tsuzuki K; Tadokoro M; Miyatake K; Sasaki T; Yokota N; Hamada N; Kariya S; Hitomi J; Nishioka A; Nakajima K; Ikeda M; Sano S; Inomata T
    Oncol Rep; 2008 Jun; 19(6):1389-94. PubMed ID: 18497941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Respective roles of radiotherapy and chemotherapy in adjuvant treatment of cancer of the breast: theoretical importance and feasibility of chemoradiotherapy].
    Freyer G; Romestaing P
    Cancer Radiother; 1998 Dec; 2(6):723-31. PubMed ID: 9922780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain metastases of breast cancer.
    Melisko ME; Kunwar S; Prados M; Berger MS; Park JW
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):253-68. PubMed ID: 15877523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent developments in radiosensitization.
    Linam J; Yang LX
    Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiation and chemotherapy sensitizers and protectors.
    Coleman CN; Turrisi AT
    Crit Rev Oncol Hematol; 1990; 10(3):225-52. PubMed ID: 2257086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiosensitization effect of Huaier on breast cancer cells.
    Ding X; Yang Q; Kong X; Haffty BG; Gao S; Moran MS
    Oncol Rep; 2016 May; 35(5):2843-50. PubMed ID: 26935024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective.
    Verheij M; Vens C; van Triest B
    Drug Resist Updat; 2010; 13(1-2):29-43. PubMed ID: 20167530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.